Simplex Trading, LLC Esperion Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$195 Billion
Q3 2025

A detailed history of Simplex Trading, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 202,089 shares of ESPR stock, worth $586,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares

202,089

Previous 230,463 12.31%

Holding current value

$586,058

Previous $226,000 136.73%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$0.98 - $2.84 $27,806 - $80,582	-28,374 Reduced 12.31%	202,089 $535,000
Q2 2025 Aug 05, 2025	BUY	$0.73 - $1.41 $61,117 - $118,048	83,722 Added 57.05%	230,463 $226,000
Q1 2025 May 12, 2025	BUY	$1.44 - $2.34 $211,307 - $343,373	146,741 New	146,741 $211,000
Q3 2024 Nov 08, 2024	BUY	$1.61 - $2.73 $20,149 - $34,165	12,515 Added 13.63%	104,359 $172,000
Q2 2024 Jul 25, 2024	BUY	$1.84 - $3.24 $168,992 - $297,574	91,844 New	91,844 $203,000

Q3 2023 Nov 01, 2023	SELL	$0.96 - $1.79 $41,018 - $76,483	-42,728 Reduced 80.1%	10,618 $10,000
Q2 2023 Aug 04, 2023	SELL	$1.2 - $1.76 $50,697 - $74,356	-42,248 Reduced 44.2%	53,346 $74,000
Q1 2023 Apr 27, 2023	SELL	$1.46 - $7.3 $63,996 - $319,980	-43,833 Reduced 31.44%	95,594 $151,000
Q4 2022 Feb 02, 2023	BUY	$5.09 - $8.5 $709,683 - $1.19 Million	139,427 New	139,427 $868,000
Q3 2021 Oct 28, 2021	SELL	$11.34 - $21.37 $1,134 - $2,137	-100 Reduced 0.67%	14,802 $316,000
Q2 2021 Aug 12, 2021	BUY	$19.4 - $28.71 $173,552 - $256,839	8,946 Added 150.2%	14,902 $315,000
Q1 2021 Apr 26, 2021	SELL	$25.12 - $36.89 $108,116 - $158,774	-4,304 Reduced 41.95%	5,956 $167,000
Q4 2020 Feb 02, 2021	SELL	$24.2 - $35.76 $196,600 - $290,514	-8,124 Reduced 44.19%	10,260 $266,000
Q3 2020 Oct 14, 2020	SELL	$31.18 - $52.71 $32,021 - $54,133	-1,027 Reduced 5.29%	18,384 $683,000
Q2 2020 Jul 13, 2020	SELL	$30.04 - $51.31 $680,135 - $1.16 Million	-22,641 Reduced 53.84%	19,411 $995,000
Q1 2020 Apr 29, 2020	BUY	$27.44 - $73.84 $896,711 - $2.41 Million	32,679 Added 348.65%	42,052 $1.33 Million
Q4 2019 Feb 05, 2020	BUY	$35.4 - $59.82 $122,908 - $207,695	3,472 Added 58.84%	9,373 $558,000
Q3 2019 Oct 15, 2019	SELL	$34.47 - $47.53 $352,972 - $486,707	-10,240 Reduced 63.44%	5,901 $216,000
Q2 2019 Jul 26, 2019	BUY	$40.1 - $52.33 $137,663 - $179,648	3,433 Added 27.01%	16,141 $750,000
Q1 2019 Apr 18, 2019	SELL	$40.11 - $53.57 $43,198 - $57,694	-1,077 Reduced 7.81%	12,708 $0
Q4 2018 Jan 16, 2019	BUY	$36.99 - $59.11 $374,634 - $598,666	10,128 Added 276.95%	13,785 $634,000
Q3 2018 Oct 23, 2018	BUY	$40.74 - $51.41 $47,217 - $59,584	1,159 Added 46.4%	3,657 $162,000
Q2 2018 Jul 30, 2018	BUY	$36.2 - $76.4 $48,363 - $102,070	1,336 Added 114.97%	2,498 $97,000
Q1 2018 Apr 26, 2018	BUY	$65.94 - $80.76 $76,622 - $93,843	1,162 New	1,162 $84,000
Q4 2017 Jan 10, 2018	SELL	$43.47 - $67.43 $171,402 - $265,876	-3,943 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$43.8 - $52.77 $172,703 - $208,072	3,943	3,943 $197,000

Others Institutions Holding ESPR

# of Institutions

215

Shares Held

113M

Call Options Held

643K

Put Options Held

769K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $193M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Esperion Therapeutics, Inc. Transaction History